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Purpose of review
This review considers recent insights into the neurobiology of repair after stroke in
animals and humans, the range of emerging therapies to promote repair and recovery
after the acute phase of stroke, and issues related to optimizing trials of such therapies
Recent findings
Animal studies continue to shed light on the molecular, vascular, glial, neuronal,
behavioral, and environmental events that are important to the spontaneous behaviora
recovery that is observed during the weeks after a stroke. Animal and human studies are
examining a wide range of potential interventions that may favorably modify outcome
including small molecules, growth factors, cell-based approaches, electromagnetic
stimulation, a range of devices and robots, and intense physiotherapy methods,
including constraint-induced movement therapy. Optimal prescription of these
restorative therapies in human patients with stroke requires further study, including
defining potential roles for functional neuroimaging.
Summary
A wide range of therapies shows promise for improving poststroke brain repair. Insights
into the neurobiology of brain repair after stroke in animals and in humans continue to
accrue. This information might prove useful in designing and implementing clinical trials
that aim to measure the clinical effects of restorative therapies after stroke.
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1350-7540Introduction
Stroke remains a leading cause of death and disability in
the USA andmany other countries. It can cause deficits in
a number of neurologic domains, most commonly in the
motor system [1]. In most patients some degree of
spontaneous behavioral recovery is observed during the
weeks to months after stroke onset [2,3]. This recovery is
generally incomplete, however. A key challenge is to
elucidate the mechanisms of spontaneous behavioral
recovery after stroke, and to use this information to guide
optimal prescription of restorative therapeutics after
stroke.
Clinical studies of the natural history of behavioral
recovery after stroke show divergent patterns across
different domains of neurologic function. Nakayama
et al. [2] found that maximum arm motor function was
achieved by 95% of patients within 9 weeks. Pedersen
et al. [4] found that final level of language function was
achieved in 95% of patients by 6 weeks poststroke. Hier
et al. [5] also found that recovery from neglect was largely
complete by 3 months. One pattern across these and
other studies is that individuals with more severe deficits
recover over a longer time period.1350-7540  2008 Wolters Kluwer Health | Lippincott Williams & Wilkins.
l
,Animal studies have provided clues to a number of the
key molecular events that are important to spontaneous
recovery after stroke [6–8,9,10]. Direct measure of these
molecular events is generally not possible in humans.
Brain mapping can be used to derive insights into the
basis of spontaneous recovery after stroke in humans,
however, and many results have been concordant with
findings in animals. Recent reviews have considered this
issue [11–13].
A critical determinant of behavioral outcome in humans is
the function of elegant and eloquent neocortical areas
that, at prestroke baseline, are central to generation of
behaviors such as movement, language, and attention.
The extent to which these areas are injured and exhibit
reduced function has a primary influence on behavioral
outcome [14,15]. Probing the function of primary
neocortex after stroke is complicated by the difficulty
of disentangling the effects of injury from plasticity.
Depending on the topography of injury, the location of
cortical function can be displaced to neighboring
areas [16,17], a process that arises independently of
other poststroke plasticity events such as change in
inter-hemispheric balance [18]. Other studies have found
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reorganization after stroke [19]. Regional changes in brain
function after stroke can have anatomic correlates such as
increased cortical thickness [20].
Although activation in the peri-infarct zone has been
specifically noted [21–23], its behavioral significance
remains to be fully clarified. One recent functional
magnetic resonance imaging (fMRI) study of patients
with cortical stroke did not identify a significant
correlation between extent of peri-infarct activation
and behavioral outcome after stroke [24]. This assess-
ment was complicated, however, by the additional
observation that the T2-weighted MRI signal
used to measure brain activation with fMRI was itself
altered in the peri-infarct zone, perhaps because of glial
scarring.
Increased activation within multiple nodes of secondary,
association cortex that together comprise a distributed
network is a common poststroke activation pattern
[17,21,25–27], described in brain networks related to a
range of neurologic domains including motor, language,
and attention functions. Maintenance of behavioral
output after injury to one node of a network is associated
with increased activation within surviving network areas.
This extends to the contralesional hemisphere, where
increased recruitment after stroke is seen and can be
quantitated via a laterality index [21], methods for which
have been refined [28]. Such increases in activation are
greatest in those with the poorest behavioral outcome or
largest lesions [18,28–30].Recent observations related to spontaneous
recovery in animals
Recent studies have substantiated that spontaneous
behavioral recovery after unilateral infarct occurs on
the basis of a wide range of bilateral growth-related brain
events. These include axonal, dendritic, and synaptic
changes; increased activation and migration of endoge-
nous neural stems; and changes in glia, inflammation, and
angiogenesis [7,9,10]. In many cases, a better under-
standing of these processes might assist in defining
therapeutic targets for improving poststroke brain repair
in humans via pharmacologic [31–36], cell-based [37,38],
immune-based [39,40], gene transfer [41], and physical
[42] therapeutic approaches. A number of factors can
influence these repair-related events, such as infarct size
or degree of environmental enrichment [43]. Dancause
et al. [44] described a specific form of neuroanatomic
reorganization distant from infarct, whereby primates
with primary motor cortex injury produce a novel
projection from ventral premotor cortex to somatosensory
cortex; this model of poststroke remodeling might prove
particularly instructive.MRI studies have also been instructive. van der Zijden
et al. [45] used MRI to measure changes in brain region
connectivity in rats subjected to occlusion of the middle
cerebral artery. This is of particular importance because,
as with previous work from this laboratory on fMRI in rats
with experimental stroke [46], the MRI investigational
approach is similar to that used in humans. Therefore, the
potential for direct comparison and translation to the
human experience is high.Recent observations related to spontaneous
recovery in humans
Numerous profound changes evolve in the brain during
the early days after stroke [47]. Significant changes in
organization of brain function can arise as late as 12months
after stroke, however [48]. Despite this wide range,
Woldag et al. [49] found that day 7 clinical assessments
have the strongest predictive value for final behavioral
outcome.
The influences that drive poststroke repair continue to
be clarified. The degree of vascular insult needed to
incite repair-related reorganization might be much
lower than was previously appreciated [50]. The specific
tracts injured by stroke could be important to elucidat-
ing patterns of deficits, plasticity, and treatment
response [19,51,52]. Ward et al. [53], in a study of
eight patients, found that a compensatory increase in
regional fMRI activation within several bilateral brain
areas, including both primary and secondary motor
cortices, was linearly related to the degree of reduction
in transcranial magnetic stimulation (TMS) measures of
motor cortex/corticospinal tract functional integrity.
Studies have confirmed that inhibition of the ipsile-
sional hemisphere by the contralesional hemisphere – a
potentially important process whose modulation might
be useful for improving cortical output – can be
increased after stroke [54], although the mechanisms
underlying this finding require further study [55].
Several lines of evidence, including virtual lesions
[56,57] and other investigative approaches [58],
indicate that bilateral supranormal activations arising
after stroke – whatever their basis is and despite the
fact that they are seen most often in weaker patients –
do contribute to whatever behavioral recovery spon-
taneously arises after stroke. Inflammation has an
important relationship with poststroke repair [59],
highlighting the importance of reports of microglia
traffic measurement during the first month after stroke
[60].
One principle emerging across human brain studies is
that baseline functional anatomy influences the pattern of
poststroke functional anatomy. Thus, swallowing [61],
facial movement [18], and gait [62] are normally more
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Also, after stroke, a shift away from the ipsilesional
hemisphere in the balance of hemispheric activity occurs
most often and with greatest clinical gains in these tasks.
This principle suggests the hypothesis that behaviors that
are more bilaterally organized in the normal state might
benefit from a more bilateral approach to therapy.
Genetic factors probably also have important influences on
poststroke repair in humans. Brain-derived neurotrophic
factor (BDNF) is among themost abundant growth factors
in mammalian brain, being necessary for many neuronal
functions. A single nucleotide polymorphism producing a
valine to methionine amino acid substitution at codon
66 occurs in one or both human alleles in more than
27% of the American population [63]. Kleim et al. [64]
found that individuals with the BDNF val66met poly-
morphism in one or both alleles exhibited significantly
impaired short-term experience-dependent motor cortex
plasticity. Given the importance of cortical plasticity to
behavioral recovery after stroke, this finding suggests that
this polymorphism might have an important influence on
behavioral outcome after stroke. Observations such as
those of Siironen et al. [65], who found that the presence
of this polymorphismwas associatedwith apoorer outcome
after subarachnoid hemorrhage, support this hypothesis.
Examination of the phases of brain repair during the
weeks after a stroke suggests distinct poststroke temporal
epochs, each requiring specific therapeutic approaches.
Similar models have been described in themotor [66] and
language [13] systems.Promoting repair after stroke
A number of therapies, representing divergent
approaches, are in development to enhance behavioral
outcome beyond that attained spontaneously. The state
of development of these therapies ranges from preclinical
investigation to late phase human trials.
A number of small molecules show promise for promoting
brain repair after stroke. Some, such as extended-release
niacin [67] and sildenafil [35], have prior human appli-
cations in other medical indications. Hopes have been
high for amphetamine in light of prior small positive
reports, but a randomized, double-blind, placebo-
controlled trial of 5 weeks of amphetamine in 71 patients
with subacute stroke did not demonstrate a drug-
related benefit [68]. Neutralization of the axon growth
inhibitor Nogo-A with monoclonal antibodies might be
useful in a number of neurologic conditions, including
stroke [40].
Growth factors play an important role in development
and spontaneous brain remodelling, and so it is notsurprising that they are emerging as potentially
important restorative agents. Examples of preclinical
effectiveness with exogenous growth factors include
BDNF [69] and granulocyte-colony stimulating factor
[36]. Kolb et al. [34] found that sequential administration
of epidermal growth factor and erythropoietin reduced
deficits, in some cases when treatment was initiated
7 days after stroke onset, with this on the heels of
a positive small study showing safety and benefits
from erythropoietin delivered within 8 h of stroke
onset in humans [70]. The issue of the blood–brain
barrier effects on accessing biologic targets might be
important, with a solution being use of a ‘trojan horse’
approach [38].
The use of exogenous cells is receiving increased atten-
tion in stroke. A small trial in human patients with
subacute stroke found marrow stromal cells to be safe
and possibly effective in reducing disability [71].
The time window after stroke during which intravenous
marrow stromal cells improve final outcome in rats
is now known to be at least 1 month [72]. Other
forms of exogenous stem cells have shown promise in
related neurologic conditions [73,74]. Genetic modifi-
cation of marrow stromal cells permits local delivery of
specific growth factors, with behavioral gains [37,75–
77]. Inducing changes in the number and behavior of
endogenous stem cells might also be an important
approach [78].
The brain is an electrical organ, and not surprisingly
electromagnetic stimulation can modulate a number of
functions and behaviors. Repetitive TMS can have
inhibitory or excitatory effects on cortical activity [79].
As such, goals can include increasing activity in
ipsilesional cortical regions that are underactive
[80,81], or in contralesional cortical regions that are over-
active and a source of potentially harmful inhibition [82].
Transcranial direct current stimulation has also shown
promise in initial studies [83]. Epidural motor cortex
stimulation can also improve motor function after stroke
[83]. In these approaches, brain mapping studies might
be useful to direct the site of stimulation [84].
A number of devices that interface directly and indirectly
with the human central nervous system are in develop-
ment to improve function after stroke. Examples include
a direct brain–computer interface to modulate motor
function [85] or alertness [86]. Methods for less invasive
acquisition of brain output to drive such devices are
under exploration [87]. Robotic devices continue to be
developed to improve functional status after stroke [88].
Robotic therapies offer potential advantages in that they
can be active without fatigue for very long time periods,
they can perform in a consistent and precise manner, they
can be programmed, they have the capacity to measure
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rehabilitation [89,90]. Functional electrical stimulation
can also improve outcome after stroke [91].
Physiotherapy interventions will probably be an important
component of many restorative therapies, alone or as an
adjunct. The EXCITE (Extremity Constraint Induced
Therapy Evaluation) trial, a single-blind, customary
care-controlled, randomized, multisite trial of 222 patients
with moderate motor deficits from a first stroke 3–
9 months previously, demonstrated effectiveness of
constraint-induced movement therapy (CIMT) [92].
Although evidence suggests that increased time in therapy
early after stroke can improve functional outcome [93],
application of CIMT very early after stroke at high inten-
sity can be deleterious [94]. Modified forms of CIMT
might increase the fraction of patients who benefit
from this intervention [95]. A number of other forms of
therapy are also under evaluation, including motor
imagery, observation, and imitation, including use of
virtual reality approaches [96–101].Optimizing approaches to repairing the brain
after stroke in humans
Maximal gains from these restorative therapies might be
achieved if they are applied in light of insights into the
neurobiology of poststroke repair presented above. Thus,
measurement of features of central nervous system
function might serve as guides to some features of
restorative therapies after stroke. There are numerous
examples in the practice of medicine whereby the
physiologic state of the target tissue is probed to guide
decision making and thereby maximally reduce symp-
toms. Examples include use of pulmonary function tests
to guide treatment of chronic obstructive pulmonary
disease, measurement of serum thyroid-stimulating
hormone to guide treatment of hypothyroidism, and
use of exercise treadmill testing to guide treatment of
coronary artery disease.
Approaches to applying functional neuroimaging in this
context are at a relatively early stage. One domain of
application is as a biologic marker of treatment effect,
providing secondary measures of treatment effect as well
as insights into treatment mechanism. One recent
meta-analysis [102] examined studies that have employed
functional neuroimaging as a biologic marker of treatment
effects targeting stroke. Conclusions across 13 studies
included thatmotor deficits have beenmost often studied,
that published studies have focused on patients with good
to excellent outcome at baseline, and that there is a paucity
of functional neuroimaging conducted to examine treat-
ment effects during the first few months after stroke. The
review also concluded that further study is required into
the effects of key variables such as lesion site, concomitantdiagnoses (e.g. depression), sex, and age on the perform-
ance of functional neuroimaging in this context.
Another domain of application is to predict treatment
response; such data might be useful in patient selection.
A number of initial efforts in this direction have been
reported, in small cohorts. Stinear et al. [103] examined
17 patients with chronic stroke. Baseline measures that
predicted motor gains across 30 days of motor practice
therapy included fractional anisotropy, a diffusion tensor-
based measure of white matter integrity, in the posterior
limb of internal capsule. Results varied according to
physiologic properties of the corticospinal system. Cramer
et al. [104] examined 24 patients with chronic stroke
before and after 6 weeks of rehabilitation therapy with
or without investigational motor cortex stimulation.
Several baseline measures correlated with subsequent
trial-related clinical gains and were entered into a forward
stepwise multiple linear regression model, which found
that two baseline measures had independent value for
predicting clinical gains: baseline arm motor status and an
fMRI-based measure of motor cortex function (with lower
motor cortex activation predicting greater potential to
improve with therapy). Interestingly, greater treatment-
related gains were associated with greater increases in
motor cortex activation over time. Koski et al. [105] found
that change in TMS measures across the first two therapy
sessions predicted response to subsequent weeks of
motor therapy. Dong et al. [106] found that the fMRI
laterality index midway through motor therapy predicted
subsequent behavioral gains. The latter two studies
suggest that functional neuroimaging might also be able
to aid in selection of restorative therapy dose.
A number of other avenues are under study to improve
the approaches used to administer restorative therapies
after stroke. Establishment of standardized protocols for
functional neuroimaging might reduce several sources of
variance [107,108]. Disentangling behavioral compen-
sation from actual recovery might be of high importance
[109]. Assessment of a range of neurologic domains might
maximize the likelihood of detecting changes in a subset
of neurologic domains, an approach that is more difficult
when relying exclusively on global neurologic scales to
measure therapeutic effects.Conclusion
Studies in animals have provided insights into the
neurobiology of spontaneous behavioral recovery after
stroke, and in doing so they have helped to define a
number of therapeutic targets to improve outcome
further. Brain mapping studies have provided insights
into this repair in humans, with results showing many
points of overlap with animal studies. Furthermore, brain
mapping can be a useful source of information relevant to
80 Cerebrovascular diseasedecision making in the setting of a restorative interven-
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